Author

Jingliang Wu

Institution: Weifang University of Science and Technology

Observed institutions: Chinese Center For Disease Control and Prevention, Weifang University of Science and Technology, National Institutes for Food and Drug Control, National Institute for Viral Disease Control and Prevention

OpenAlex ID: A5111142237

Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

2021 · Hongxing Pan, Jiankai Liu, et al. · The Journal of Infectious Diseases · 19

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis

2024 · Xueying Ding, Shujie Sun, et al. · Frontiers in Pharmacology · 5

Chemotherapy-photothermal liposomes modified by DNA-protein network inhibit oral squamous cell carcinoma progression basing on regulating tumor microenvironment

2026 · Jingliang Wu, Yu Xiu, et al. · International Journal of Biological Macromolecules · 3

Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer

2024 · Ben Yang, Rongguan Kou, et al. · International Journal of Molecular Medicine · 3

Application of nanozyme-based drug delivery systems in the treatment of ROS-related ophthalmic diseases

2026 · Zhipeng Li, Keda Yan, et al. · International Journal of Pharmaceutics X

Works count: 5

Citation count: 30

H-index: 3

I10-index: 1